Wei Wei

Fibroadenomas are common benign breast tumors, but recurrent bilateral giant fibroadenomas are rare. Recent studies suggest genetic factors, such as PIK3CA mutations, may influence tumor behavior. A 23-year-old woman with prior multiple fib…

Background Ovarian endometriotic cysts (OEC) represent the primary manifestation of endometriosis, constituting a hormonally dependent inflammatory disorder in gynecology. It significantly affects the quality of life and reproductive health…

OBJECTIVE: Elagolix is approved for the treatment of moderate-to-severe pain associated with endometriosis. However, the long-term safety of elagolix in a large sample of real-world patients is unknown. METHODS: The U.S. Food and Drug Admi…

BACKGROUND: Elagolix, an approved non-peptide GnRH antagonist, shows promise in relieving endometriosis-related pain, but its short- and mid-term efficacy and potential side effects are still under investigation. OBJECTIVE: The aim is to p…

This was a retrospective study that evaluated a total of 280 patients who underwent surgery for complete removal of endometriosis to develop and validate the predictive model for stage IV endometriosis. The differences between stage I-III a…

eview question / Objective The aim of this study is to comprehensively analyze evidence of elagolix in the treatment of moderateto-severe endometriosis-associated pain.Condition being studied Endometriosis-related pain, such as dysmenorrhea…

BACKGROUND: Endometriosis is a chronic condition that affects women of child-bearing age. Since the etiology and pathogenesis of endometriosis have not been fully elucidated, it is important to investigate the mechanisms that lead to the de…